Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin;Les insuffisances rénales aiguës aux quinolones. Revue générale à propos d'une observation avec cristallisation liée à la ciprofloxacine

Nephrologie et Therapeutique

Volumn 1, Issue 1, 2005, Pages 44-51

  Montagnac, Richard ^a   Briat, Claude ^b   Schillinger, Francis ^a   Sartelet, Hervé ^c   Birembaut, Philippe ^c   Daudon, Michel ^d  

^a CENTRE HOSPITALIER DE TROYES   (France)

^b Service d'Urologie   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Acute interstitial nephritis; Acute renal failure; Acute tubular necrosis; Crystalluria; Fluoroquinolones

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CRYSTALLURIA; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INJURY;

EID: 23244445374     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2005.02.005     Document Type: Article

References (75)

1. Arcieri G, August R, Becker N, Doyle C, Griffith E, Gruenwaldt G, et al. Clinical experience with ciprofloxacin in the USA. Eur J Clin Microbiol 1986;5:220-5.
2. Gerritsen W, Peters A, Henny F, Brouwers J. Ciprofloxacin-induced nephrotoxicity. Nephrol Dial Transplant 1987;5: 382-3.
3. Ball P. Adverse reactions and interactions of fluoroquinolones. Clin Invest Med 1989;1:28-34.
4. Connor J, Curry J, Selby T, Perlmutter A. Acute renal failure secondary to ciprofloxacin use. J Urol 1994;4: 975-6.
5. Scheen A. Effets secondaires des fluoroquinolones: l'expérience de la pharmacovigilance française. Rev Med Liege 1995;11:492-3.
6. Walker R. The fluoroquinolones. Mayo Clin Proc 1999;74: 1030-7.
7. Halkin H. Adverse effects of the fluoroquinolones. Rev Infect Dis 1988;10(suppl.1):S258-61.
8. Rahm V, Schacht P, Safety of ciprofloxacin. A review. Scand J Infect Dis 1989;(suppl.60):120-8.
9. Hatton J, Haagensen D. Renal dysfunction associated with ciprofloxacin. Pharmacotherapy 1990;5:337-40.
10. Lo W, Rolston K, Rubenstein E, Bodey G. Ciprofloxacin-induced nephrotoxicity in patients with cancer. Arch Intern Med 1993;153:1258-62.
11. Lietman P. Fluoroquinolone toxicities. An Update. Drugs 1995;49(Suppl.2):159-63.
12. Christ W, Lehnert T, Ulrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988;10(Suppl.1):S41-6.
13. Arvieux C, Charasse C, Guilhem I, Rivalan J, Le Pogamp P, Ramée MP. Insuffisance rénale aiguë par néphropathie tubulo-interstitielle après traitement par ciprofloxacine. Ann Med Interne (Paris) 1991;7:554-6.
14. Patterson D. Quinolone toxicity: methods of assessment. Am J Med 1991;91(suppl.6A):35S.
15. Stubbings J, Sheehan-Dare R, Walton S. Cutaneous vasculitis due to ciprofloxacin. BMJ 1992;305:29.
16. Kundu A. Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult. Assoc Physicians India 2000;48:649-50.
17. Davis H, Mc Goodwin E, Reed T. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989;111:1041-3.
18. Gauffre A, Mircheva J, Glotz D, Fillastre JP, Simon P, Beaune P, et al. Autoantibodies against a kidney-liver protein associated with quinolone-induced acute interstitial nephritis or hepatitis. Nephrol Dial Transplant 1997;12: 1961-2.
19. Deamer R, Prichard J, Koenker N, James R, Heming D. Temafloxacin-induced haemolytic anemia and renal failure. Clin Pharm 1993;5:380-2.
20. Maguire R, Stroncek D, Gale E, Yearsley M. Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies. Am J Hematol 1994; 4:363-6.
21. Lim S, Alam M. Ciprofloxacin-induced acute interstitial nephritis and auto-immune haemolytic anemia. Ren Fail 2003;4:647-51.
22. Meyer D. Overview of toxicological studies. Drugs 1987; 34(suppl.1):150-3.
23. Schluter G. Ciprofloxacin: review of potential toxicologic effects. Am J Med 1987;82(suppl.4A):91-3.
24. Garlando F, Tauber M, Joos B, Oelz B, Luthy R. Ciprofloxacin-induced hematuria. Infection 1985;13: 177-8.
25. Thorsteinsson S, Bergan T, Oddsdottir S, Rohwedder R, Holm R. Crystalluria and ciprofloxacin, Influence of urinary pH and hydration. Chemotherapy 1986;32:408-17.
26. Campoli-Richards D, Monk JP, Price A, Berfield P, Todd P, Ward A. Ciprofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic uses. Drugs 1988;4:373-447.
27. Hootkins R, Fenves A, Stephens M. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature. Clin Nephrol 1989;2:75-8.
28. Moore N, Breemeersch C, Noblet C. Renal failure with fluoroquinolones. Therapie 1996;51:421-3.
29. Lomaestro B. Fluoroquinolone-induced renal failure. Drug Saf 2000;22:479-85.
30. Ramalakshmi S, Bastacky S, Johnson J. Levofloxacin-induced granulomatous interstitial nephritis. Am J Kidney Dis 2003;2:E7.
31. Solomon N, Mokrzycki M. Levofloxacin-induced allergic interstitial nephritis. Clin Nephrol 2000;54:356 (letter).
32. Famularo G, De Simone C. Nephrotoxicity and purpura associated with levofloxacin. Ann Phamacother 2002;9: 1380-2.
33. Mac Aulay S, Bayliff C, Mehta S. Fluoroquinolone - induced acute interstitial nephritis: two case reports. CJ HP 2002; 2:139-42.
34. Boelaert J, de Jaegere P, Daneels R, Schurgers M, Gordts B, van Landuyt H. Case report of renal failure during norfloxacin therapy. Clin Nephrol 1986;5:272 (letter).
35. Hadimeri H, Almroth G, Cederbrant K, Eneström S, Hultman P, Lindell A. Allergic nephropathy associated with norfloxacin and ciprofloxacin therapy. Scand J Urol Nephrol 1997;31:481-5.
36. Nakamura M, Ohishi A, Aosaki N, Hagamuchi K. Norfloxacin-induced acute interstitial nephritis. Nephron 2000;86:204-5 (letter).
37. Jungst G, Mohr R. Side effects of ofloxacin in clinical trials and in post-marketing surveillance. Drugs 1987; 34(suppl.1):144-9.
38. Huminer D, Cohen J, Majadla R, Dux S. Hypersensitive vasculitis due to ofloxacin. BMJ 1989;299:303.
39. Espiritu J, Walton T. Acute renal failure due to ofloxacin. W V Med J 1995;1:16.
40. Blum M, Graham D, McCloskey C. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994;18:946-50.
41. Yew W, Chau C, Wong P, Choi H. Ciprofloxacin induced renal dysfunction in patients with mycobacterial lung infections. Tuber Lung Dis 1995;76:173-5.
42. Rastogi S, Atkinson J, Mc Carthy J. Allergic nephropathy associated with ciprofloxacin. Mayo Clin Proc 1990;65: 987-9.
43. Rippelmeyer D, Synhavsky A. Ciprofloxacin and allergic interstitial nephritis. Ann Intern Med 1988;109:170.
44. Ying L, Johnson C. Ciprofloxacin-induced interstitial nephritis. Clin Pharm 1989;8:518-21.
45. Allon M, Lopez E, Min K. Acute renal failure due to ciprofloxacin. Arch Intern Med 1990;10:2187-9.
46. Helmink R, Bunediktsson H. Ciprofloxacin-induced allergic interstitial nephritis. Nephron 1990;55:432-3.
47. Bailey J, Trott S, Philbrick J. Ciprofloxacin-induced acute interstitial nephritis. Am J Nephrol 1992;4:271-3.
48. Ortiz A, Plaza J, Egido J. Ciprofloxacin-associated tubulointerstitial nephritis with linear tubular basement membrane deposits (Letter to the Editor). Nephron 1992;60: 248.
49. Lien Y, Hansen R, Kern W, Bangert J, Nagle R, Ko M, et al. Ciprofloxacin-induced granulomatous interstitial nephritis and localized elastolysis. Am J Kidney Dis 1993;4:598-602.
50. Rolston K, Rubenstein E. Ciprofloxacin nephrotoxicity. Arch Intern Med 1993;153:2705-6 (letter).
51. Shih D, Korbet S, Rydel J, Schwartz M. Renal vasculitis associated with ciprofloxacin. Am J Kidney Dis 1995;3: 516-9.
52. Reece R, Nicholls A. Ciprofloxacin-induced acute interstitial nephritis. Nephrol Dial Transplant 1996;11:393.
53. Dharnidharka V, Nadeau K, Cannon C, Harris H, Rosen S. Ciprofloxacin overdose: acute renal failure with prominent apoptotic changes. Am J Kidney Dis 1998;4:710-2.
54. Murray K, Wilson M. Suspected ciprofloxacin-induced interstitial nephritis. DICP 1990;24:379-80.
55. Rosado L, Siskind M, Copeland J. Acute interstitial nephritis in a cardiac transplant recipient receiving ciprofloxacin. J Thorac Cardiovasc Surg 1994;5:1364.
56. Raja N, Miller WE, McMillan R, Mason JR. Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescue. Bone Marrow Transplant 1998;12:1283-4.
57. George MJ, Dew 3rd RB, Daly JS. Acute renal failure after an overdose of ciprofloxacin. Arch Intern Med 1991;151: 620.
58. Haron E, Rolston K, Cunningham C, Hommes F, Umsawasdi T, Bodey G. Oral ciprofloxacin therapy for infections in cancer patients. J Antimicrob Chemother 1989;24:955-62.
59. George MJ, Dew 3rd RB, Daly JS. Acute renal failure after an overdose of ciprofloxacin. Arch Intern Med 1991;151: 620.
60. Anderson I, Sjöström P. Ciprofloxacin can cause allergic interstitial nephritis with acute renal failure. Lakartidningen 1991;88:1298-9.
61. Gonski PN. Ciprofloxacin-induced renal failure in an elderly patient. Med J Aust 1991;9:638-9.
62. Ball P, Tillotson G. Tolerability of fluoroquinolone antibiotics. Drug Saf 1995;13:343-58.
63. Nakano M, Ishihara S, Deguchi T, Kuriyama M, Kawada Y. Fluoroquinolone associated bladder stone. J Urol 1997;3: 946.
64. Chopra N, Fine P, Price B, Atlas I. Bilateral hydronephrosis from ciprofloxacin induced crystalluria and stone formation. J Urol 2000;164:438.
65. Choe U, Rotscchild B, Laitman L. Ciprofloxacin-induced vasculitis. N Engl J Med 1989;320:257-8.
66. Andrews P, Robinson G. Intravascular hemolysis and interstitial nephritis in association with ciprofloxacin. Nephron 1999;83:359-60.
67. Slama T. Serum sickness-like illness associated with ciprofloxacin. Antimicrob Agents Chemother 1990;34:904-5.
68. Falkenberg F, Mondorf A. Investigation on renal tolerability of ciprofloxacin with tests based on monoclonal antibodies. Infection 1988;16(Suppl.1):S69-72.
69. Bald M, Ratien F, Nikolaizik W, Wingren A. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. Pediatr Infect Dis J 2001;3:320-1.
70. Geffriaud-Ricouard C, Jungers P, Chauveau D, Grunfeld JP. Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet 1993;341:1475.
71. Pruna A, Metivier F, Akposso K, Saltiel C, Bedrossian J, Idatte JM, et al. Pefloxacin as first-line treatment in nephrotic syndrome. Lancet 1992;340:728-9.
72. Avent K, Krinsky D, Kirklin J. Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine. Am J Med 1988;85: 452-3.
73. Elston R, Taylor J. Possible interaction of ciprofloxacin with cyclosporin A. J Antimicrob Chemother 1988;5:679-80.
74. Ljunberg B, Nilsson-Ehle I. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance. Eur J Clin Microbiol Infect Dis 1989;8:515-20.
75. Lucena M, Marquez M, Velasco J, Andrade R. Acute renal failure attributable to ciprofloxacin in a patient with the acquired immunodeficiency syndrome. Arch Intern Med 1995;155:114-5.